Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ardelyx Inc
(NQ:
ARDX
)
8.720
+1.930 (+28.42%)
Official Closing Price
Updated: 4:15 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ardelyx Inc
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
March 02, 2023
Via
Benzinga
Ardelyx Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 02, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx Publishes First Environmental, Social and Governance (ESG) Report
February 28, 2023
Report focuses on patient access and affordability, workforce wellness and training, community involvement and sound corporate governance
From
Ardelyx, Inc.
Via
GlobeNewswire
7 Smart Stock Picks for Cautious Investors
February 28, 2023
As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors.
Via
InvestorPlace
Why Ardelyx Shares Are Falling
January 19, 2023
Ardelyx Inc (NASDAQ: ARDX) shares are trading lower by 17.03% to $2.67 Thursday morning after the company filed for a mixed shelf offering of up to $250 million.
Via
Benzinga
Ardelyx to Participate at the Cowen 43rd Annual Health Care Conference
February 27, 2023
From
Ardelyx, Inc.
Via
GlobeNewswire
Ardelyx to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 2, 2023
February 23, 2023
Conference call scheduled for 4:30 p.m. Eastern Time
From
Ardelyx, Inc.
Via
GlobeNewswire
7 A-Rated Penny Stocks Worth Betting On
February 19, 2023
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.
Via
InvestorPlace
7 Stocks Under $10 to Buy in February
February 17, 2023
A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns.
Via
InvestorPlace
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
February 12, 2023
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.
Via
InvestorPlace
7 A-Rated Stocks to Buy for February 2023
February 07, 2023
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader.
Via
InvestorPlace
7 A-Rated Stocks to Buy for Less Than $25
January 24, 2023
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market.
Via
InvestorPlace
PPG Industries, Netflix, Ally Financial And Other Big Stocks Moving Higher On Friday
January 20, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 19, 2023
Via
Benzinga
5 Under-the-Radar Penny Stocks With 100% Upside Potential
January 16, 2023
Most experts will advise you to steer clear of under the radar penny stocks – and for good reason. However, keep an eye on these.
Via
InvestorPlace
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
December 31, 2022
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...
Via
Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
December 30, 2022
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday.
Via
Benzinga
Dow Surges 250 Points; Jobless Claims Rise To 225,000
December 29, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday.
Via
Benzinga
The 3 Biggest Opportunities for Penny Stock Investors in 2023
December 21, 2022
Investors should be able to profit from some of the biggest opportunities for penny stock investors identified in this column.
Via
InvestorPlace
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.
Via
Benzinga
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 19, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in...
Via
Benzinga
FDA Needs More Time For Ardelyx's Appeal To Rejection Of Kidney Disease Candidate
December 19, 2022
Via
Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
December 19, 2022
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...
Via
Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
December 18, 2022
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year.
Via
InvestorPlace
How Is The Market Feeling About Ardelyx?
December 07, 2022
Ardelyx's (NASDAQ:ARDX) short percent of float has risen 16.96% since its last report. The company recently reported that it has 8.59 million shares sold short, which is 4.62% of all regular shares...
Via
Benzinga
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
December 07, 2022
In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount...
Via
Benzinga
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In November 2022: Where Do Tesla, Apple, A Donald Trump-Linked SPAC Rank?
December 05, 2022
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via
Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.
Via
InvestorPlace
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
November 23, 2022
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Is Ardelyx is A Buy After Slip in Early 2022
November 21, 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Via
MarketBeat
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.